Collagen peptide composition for regulating metabolism and reducing weight and fat and application thereof
Through the synergistic effect of collagen peptides and plant enzymes, Lactobacillus rhamnosus and Lactobacillus casei fermentation technology, the existing drugs for treating obesity, hyperglycemia and hyperlipidemia are solved, and significant weight loss and blood sugar reduction are achieved and liver protection effects.
Patent Information
- Application Number
- CN202411123622.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-08-18
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-15
AI Technical Summary
The current drugs for treating obesity, hyperglycemia and hyperlipidemia have limited efficacy and obvious side effects. Traditional Chinese medicine takes effect slowly and is inconvenient to use medicine. There is a lack of safe and effective lipid-lowering and glucose-lowering and weight loss drugs.
Develop a collagen peptide composition, which synergizes the collagen peptide fermentation broth obtained by Lactobacillus rhamnosus NCU2217 fermentation with plant enzymes fermented by Lactobacillus casei to regulate sugar/lipid metabolism, lose weight and fat, lower blood sugar, and Protect liver damage.
Significantly regulates sugar/lipid metabolism, reduces obesity, lowers blood sugar, protects the liver, and has more significant effects than when collagen peptides or plant enzymes alone, with safe side effects.
Smart Images

Figure CN119015392A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine, and in particular to a collagen peptide composition for regulating metabolism, reducing weight and fat, and application thereof. Background Art
[0002] As the quality of life improves, high blood sugar, high blood lipids, obesity, etc. gradually threaten human health and show a trend of younger people, which has seriously affected people's quality of life. At present, the treatment of obesity, high blood sugar and high blood lipids is mainly based on Western medicine, which not only has limited efficacy, but also has obvious side effects when taken for a long time. In view of this situation, the development of safe and effective lipid-lowering, blood sugar-lowering and weight-loss drugs has become the focus of current medical research.
[0003] Compared with Western medicine, Chinese medicine has the advantages of safety, few side effects, no damage to the gastrointestinal tract, and little stimulation to the liver and kidneys, and has attracted people's attention. However, Chinese medicine has the problems of slow onset and inconvenient medication. The present invention is based on collagen peptides and Chinese medicine, supplemented by biological fermentation technology, to develop a collagen peptide composition, which has a significant effect on weight loss and fat reduction, lowering blood sugar, and regulating lipid metabolism. Summary of the invention
[0004] The purpose of the present invention is to overcome the deficiencies of the prior art and provide a collagen peptide composition and its application for regulating metabolism, reducing weight and fat, so as to solve the problems raised in the above technical background.
[0005] Chinese patent 201810978527.X (the applicant is Nanchang University) discloses Lactobacillus rhamnosus NCU2217, which was deposited in the General Microbiological Center (CGMCC) of the China Microbiological Culture Collection Administration on April 9, 2018, with a deposit number of CGMCC NO15573. The Lactobacillus rhamnosus NCU2217 used in the present invention was donated by researchers from Nanchang University.
[0006] During the research and practice, the team of the present invention found that the collagen peptide fermentation liquid obtained by fermentation of Lactobacillus rhamnosus NCU2217 and plant enzymes have a synergistic effect on regulating sugar / lipid metabolism, reducing weight and fat, and lowering blood sugar. However, the effects of using unfermented collagen peptides or collagen peptide fermentation liquid obtained by fermentation of ordinary Lactobacillus rhamnosus together with plant enzymes on regulating sugar / lipid metabolism, reducing weight and fat, lowering blood sugar and protecting liver damage are far from enough.
[0007] To achieve the above object, the present invention is implemented through the following technical solutions:
[0008] In a first aspect, the present invention provides a collagen peptide composition for regulating metabolism and reducing weight and fat, comprising collagen peptide fermentation broth and plant enzymes, wherein the volume ratio of the collagen peptide fermentation broth to the plant enzymes is 10-15:2-5; the collagen peptide fermentation broth is obtained by fermenting collagen peptides by Lactobacillus rhamnosus; and the plant enzymes are obtained by fermenting a traditional Chinese medicine composition by Lactobacillus casei.
[0009] In the above technical solution, the volume ratio of the collagen peptide fermentation liquid and the plant enzyme is 12:3.
[0010] In the above technical scheme, the specific fermentation method of the collagen peptide fermentation liquid is: add 3-5% (w / v) collagen peptide into water, inoculate Lactobacillus rhamnosus, and ferment at 30-42°C for 16-24h to obtain collagen peptide fermentation liquid.
[0011] In the above technical solution, the molecular weight of the collagen peptide is 2000-6000 Dalton; preferably, the molecular weight of the collagen peptide is 2000-3000 Dalton. Specifically, the collagen peptide adopts any one of fish collagen peptide, cowhide collagen peptide and pigskin collagen peptide. Among them, the main raw material of fish collagen peptide is fish skin; for example, fish collagen peptide, molecular weight 2000Da, purchased from Hebei Saiyi Biotechnology Co., Ltd.; cowhide collagen peptide, 2000-4000Da, purchased from Shaanxi Chenming Biotechnology Co., Ltd.; pigskin collagen peptide, molecular weight 3000Da, purchased from Shanghai Shucan Industrial Co., Ltd.
[0012] In the above technical solution, the Lactobacillus rhamnosus is Lactobacillus rhamnosus NCU2217, which is deposited in the General Microbiological Center of China National Microbiological Culture Collection Administration with a deposit number of CGMCC NO15573.
[0013] In the above technical solution, the inoculation amount of Lactobacillus rhamnosus is 1×10 6 ~1×10 7 cfu / mL.
[0014] In the above technical solution, the Chinese medicine composition contains Ganoderma lucidum, Alisma orientalis and Shenqu.
[0015] In the above technical solution, the weight ratio of Ganoderma lucidum, Alisma orientalis and Shenqu is 3:2:2.
[0016] In the above technical solution, the specific preparation method of the plant enzyme is:
[0017] (a) mixing the Chinese medicinal materials in the Chinese medicine composition in proportion and adding the mixture into distilled water for extraction, and concentrating the obtained extract to obtain a Chinese medicine concentrate;
[0018] (b) directly adding Lactobacillus casei into the Chinese medicine concentrate for inoculation and fermentation to obtain plant enzyme.
[0019] In the above technical solution, the inoculation amount of Lactobacillus casei is 1×10 6 ~1×10 7 cfu / mL.
[0020] In a second aspect, the present invention also provides the use of the above-mentioned collagen peptide composition in the preparation of health food or medicine;
[0021] Furthermore, the health food is a health food with the functions of regulating metabolism, losing weight and reducing fat.
[0022] Furthermore, the drug is a drug that has the functions of regulating metabolism, reducing weight and fat, and protecting liver damage.
[0023] Compared with the prior art, the present invention has the following beneficial effects:
[0024] 1. The synergistic effect of the collagen peptide fermentation liquid and the plant enzyme in the present invention has the effects of reducing weight and fat, lowering blood sugar, regulating sugar metabolism, lipid metabolism and protecting liver damage.
[0025] 2. The collagen peptide fermentation broth of the present invention is obtained by fermenting Lactobacillus rhamnosus NCU2217, and the plant enzyme is obtained by synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu. Only the collagen peptide fermentation broth obtained by the above method and the plant enzyme synergistically regulate sugar / lipid metabolism, lose weight and fat, lower blood sugar and protect liver damage more significantly. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 is a curve chart showing the effect of the collagen peptide composition of the present invention on the body weight of mice;
[0027] Figure 2 The figure is a bar graph showing the effect of the collagen peptide composition of the present invention on the levels of TG, TC, LDL-C, HDL-C and LEP in mouse serum;
[0028] Figure 3 The bar graph is a graph showing the effect of the collagen peptide composition of the present invention on the glycogen content in rat liver;
[0029] Figure 4 This is a bar graph showing the effect of the collagen peptide composition of the present invention on the ALT and AST levels in mouse serum;
[0030] Figure 5 It is a bar graph showing the effect of the collagen peptide composition of the present invention on the contents of SOD and MDA in mouse liver. DETAILED DESCRIPTION
[0031] The following describes the embodiments of the present invention by specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that the following embodiments and features in the embodiments can be combined with each other without conflict.
[0032] Example 1
[0033] This embodiment provides a collagen peptide composition for regulating metabolism, reducing weight and reducing fat, comprising collagen peptide fermentation broth and plant enzymes, wherein the volume ratio of the collagen peptide fermentation broth to the plant enzyme is 10:5; the collagen peptide fermentation broth is obtained by fermenting collagen peptides with Lactobacillus rhamnosus; the plant enzyme is obtained by fermenting a traditional Chinese medicine composition with Lactobacillus casei. The traditional Chinese medicine composition comprises 3 parts of Ganoderma lucidum, 2 parts of Alisma orientalis, and 2 parts of Shenqu by weight. Among them, the collagen peptide uses fish collagen peptide. Fish collagen peptide, with a molecular weight of 2000Da, was purchased from Hebei Saiyi Biotechnology Co., Ltd.
[0034] In this embodiment, the specific fermentation method of the collagen peptide fermentation liquid is: adding 5% collagen peptide to water
[0035] (w / v), and inoculated with Lactobacillus rhamnosus, and fermented at 30°C for 24 hours to obtain collagen peptide fermentation liquid. The Lactobacillus rhamnosus is Lactobacillus rhamnosus NCU2217, which is deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration, with a deposit number of CGMCC NO15573; the inoculation amount of Lactobacillus rhamnosus is 1×10 6 cfu / mL.
[0036] In this embodiment, the specific preparation method of the plant enzyme is:
[0037] (a) mixing the Chinese medicinal materials of the Chinese medicine composition in proportion and adding them to 10 times the amount of distilled water for extraction, combining the filtrates after three extractions, and concentrating the obtained extract to a crude drug concentration of 1.0 g / ml to obtain a Chinese medicine concentrate;
[0038] (b) directly adding Lactobacillus casei to the concentrated Chinese medicine solution for inoculation and fermentation, and fermenting at 37°C for 4 hours to obtain plant enzymes. The Lactobacillus casei is Lactobacillus casei ATCC 393, item number 0176P, purchased from Shenzhen Zike Biotechnology Co., Ltd.; the inoculation amount of the Lactobacillus casei is 2×10 6 cfu / mL.
[0039] Example 2
[0040] This embodiment provides a collagen peptide composition for regulating metabolism, reducing weight and reducing fat, comprising collagen peptide fermentation broth and plant enzymes, wherein the volume ratio of the collagen peptide fermentation broth to the plant enzymes is 12:3; the collagen peptide fermentation broth is obtained by fermenting collagen peptides with rhamnosus Lactobacillus NCU2217; the plant enzymes are obtained by fermenting a variety of traditional Chinese medicine compositions with Lactobacillus casei. The traditional Chinese medicine composition comprises 3 parts of Ganoderma lucidum, 2 parts of Alisma orientalis, and 2 parts of Shenqu by weight. Among them, the collagen peptide uses fish collagen peptide. Fish collagen peptide, molecular weight 2000Da, purchased from Hebei Saiyi Biotechnology Co., Ltd.
[0041] In this embodiment, the specific fermentation method of the collagen peptide fermentation liquid is: adding 4% collagen peptide to water
[0042] (w / v), and inoculated with Lactobacillus rhamnosus, and fermented at 37°C for 20 hours to obtain collagen peptide fermentation liquid. The Lactobacillus rhamnosus is Lactobacillus rhamnosus NCU2217, which is deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration, with a deposit number of CGMCC NO15573; the inoculation amount of Lactobacillus rhamnosus is 3×10 6 cfu / mL.
[0043] In this embodiment, the specific preparation method of the plant enzyme is:
[0044] (a) mixing the Chinese medicinal materials of the Chinese medicine composition in proportion and adding them to 10 times the amount of distilled water for extraction, combining the filtrates after three extractions, and concentrating the obtained extract to a crude drug concentration of 1.0 g / ml to obtain a Chinese medicine concentrate;
[0045] (b) directly adding Lactobacillus casei to the concentrated Chinese medicine solution for inoculation and fermentation, and fermenting at 37°C for 4 hours to obtain plant enzymes. The Lactobacillus casei is Lactobacillus casei ATCC 393, item number 0176P, purchased from Shenzhen Zike Biotechnology Co., Ltd.; the inoculation amount of the Lactobacillus casei is 1×10 6 cfu / mL.
[0046] Example 3
[0047] This embodiment provides a collagen peptide composition for regulating metabolism, reducing weight and reducing fat, comprising collagen peptide fermentation broth and plant enzymes, wherein the volume ratio of the collagen peptide fermentation broth to the plant enzyme is 15:2; the collagen peptide fermentation broth is obtained by fermenting collagen peptides with Lactobacillus rhamnosus; the plant enzymes are obtained by fermenting a variety of traditional Chinese medicine compositions with Lactobacillus casei. The traditional Chinese medicine composition comprises 3 parts of Ganoderma lucidum, 2 parts of Alisma orientalis, and 2 parts of Shenqu by weight. Among them, the collagen peptide uses fish collagen peptide. Fish collagen peptide, with a molecular weight of 2000Da, was purchased from Hebei Saiyi Biotechnology Co., Ltd.
[0048] In this embodiment, the specific fermentation method of the collagen peptide fermentation liquid is: add 3% collagen peptide into water
[0049] (w / v), and inoculated with Lactobacillus rhamnosus, and fermented at 42°C for 16 hours to obtain collagen peptide fermentation liquid. The Lactobacillus rhamnosus is Lactobacillus rhamnosus NCU2217, which is deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration, with a deposit number of CGMCC NO15573; the inoculation amount of Lactobacillus rhamnosus is 1×10 7 cfu / mL.
[0050] In this embodiment, the specific preparation method of the plant enzyme is:
[0051] (a) mixing the Chinese medicinal materials of the Chinese medicine composition in proportion and adding them to 10 times the amount of distilled water for extraction, combining the filtrates after three extractions, and concentrating the obtained extract to a crude drug concentration of 1.0 g / ml to obtain a Chinese medicine concentrate;
[0052] (b) directly adding Lactobacillus casei to the concentrated Chinese medicine solution for inoculation and fermentation, and fermenting at 37°C for 4 hours to obtain plant enzymes. The Lactobacillus casei is Lactobacillus casei ATCC 393, item number 0176P, purchased from Shenzhen Zike Biotechnology Co., Ltd.; the inoculation amount of the Lactobacillus casei is 1×10 7 cfu / mL.
[0053] Example 4
[0054] This example is similar to Example 2, except that the collagen peptide is bovine collagen peptide. Bovine collagen peptide, 2000-4000Da, was purchased from Shaanxi Chenming Biotechnology Co., Ltd.;
[0055] Example 5
[0056] This example is similar to Example 2, except that the collagen peptide is pig skin collagen peptide. The pig skin collagen peptide has a molecular weight of about 3000 Da and is purchased from Shanghai Shucan Industrial Co., Ltd.
[0057] Comparative Example 1
[0058] This example is similar to Example 2, except that the collagen peptide fermentation broth is replaced with a Lactobacillus rhamnosus NCU2217 bacterial broth, and the concentration of Lactobacillus rhamnosus NCU2217 in the Lactobacillus rhamnosus NCU2217 bacterial broth is 1×10 7 cfu / mL.
[0059] Comparative Example 2
[0060] This example is similar to Example 2, except that the collagen peptide fermentation broth is replaced with a 4% (w / v) collagen peptide aqueous solution.
[0061] Comparative Example 3
[0062] This embodiment is similar to embodiment 2, except that the fermentation agent used in the collagen peptide fermentation broth is different. Lactobacillus rhamnosus NCU2217 is replaced by common Lactobacillus rhamnosus, and the common Lactobacillus rhamnosus is Lactobacillus rhamnosus ATCC53103, which is purchased from Shenzhen Zike Biotechnology Co., Ltd.
[0063] Comparative Example 4
[0064] This embodiment is similar to embodiment 2, except that the Chinese medicine composition used in the plant enzyme is directly fermented without adding Lactobacillus casei. Specifically, the specific preparation method of the plant enzyme is:
[0065] (a) mixing the Chinese medicinal materials of the Chinese medicine composition in proportion and adding them to 10 times the amount of distilled water for extraction, combining the filtrates after three extractions, and concentrating the obtained extract to a crude drug concentration of 1.0 g / ml to obtain a Chinese medicine concentrate;
[0066] (b) The Chinese medicine concentrate was fermented at 37°C for 4 h to obtain plant enzymes.
[0067] Comparative Example 5
[0068] This embodiment is similar to embodiment 2, except that Ganoderma lucidum is removed from the Chinese herbal composition used in the plant enzyme.
[0069] Comparative Example 6
[0070] This embodiment is similar to Embodiment 2, except that Alisma orientalis is removed from the Chinese herbal composition used in the plant enzyme.
[0071] Comparative Example 7
[0072] This embodiment is similar to Embodiment 2, except that Shenqu is removed from the Chinese herbal composition used in the plant enzyme.
[0073] 1. Study on the function of collagen peptide composition in weight loss and regulating lipid metabolism
[0074] 1.1 Construction of obese mouse model
[0075] Mice: Kunming mice, male, weighing 20±2g, purchased from Jiangsu Ai Ling Fei Biotechnology Co., Ltd.;
[0076] Construction method: All experimental mice were fed with a basic feed. After one week of adaptive feeding, they were randomly divided into a basic feed group (6 mice) and a high-fat feed group (150 mice) according to their body weight. The basic feed, also known as SPF-grade maintenance feed for mice and rats, was purchased from Liaoning Changsheng Biotechnology Co., Ltd.; the high-fat feed formula: 79.5% basic feed, 10% lard, 10% egg yolk powder, and 0.5% cholesterol. The basic feed group continued to be fed with the basic feed as the normal group, and the high-fat feed group was fed with a high-fat feed as the model group. The mice were weighed once a week during the modeling period, and the changes in the weight of the mice were observed during the weekly feeding period. When the obesity degree was above 20%, the obese mouse model was successfully established.
[0077]
[0078] 1.2 Trial Grouping and Dosing
[0079] 96 obese mice with successful modeling were selected and randomly divided into 16 groups according to body weight, including 1 model group, 1 positive control group, and 14 treatment groups (Example 1-5, Comparative Example 1-7, collagen peptide fermentation broth and plant enzymes, respectively), to ensure that there was no significant difference in body weight between the groups, and the basal feed group was the normal group. After the grouping was completed, the experimental period began. The experimental period was 6 weeks. The model group, positive control group and treatment group continued to be fed with high-fat feed, and the blank group continued to be fed with basal feed. They were free to eat, and the food intake was recorded every day. The experimental mice were gavaged with different doses of the test samples at 8:30 am every day. The gavage dose for the normal group and the model group was: 10mL·Kg of normal saline -1 (bw / d); the oral dose of the positive control group was: orlistat 54.6 mg·Kg -1 (bw / d); The intragastric dose of the treatment group was: the compositions obtained in Examples 1-5 and Comparative Examples 1-7 were diluted 10 times with distilled water, respectively, at 10 mL·Kg -1 The collagen peptide fermentation liquid and plant enzyme were obtained in Example 2, and diluted in proportion to the dosage in Example 2 (the collagen peptide fermentation liquid was diluted 10*12 / 15 times, and the plant enzyme was diluted 10*3 / 15 times), respectively, at 10mL·Kg -1 (bw / d) dose by oral gavage.
[0080] 1.3 Detection indicators
[0081] After the end of the experimental cycle, the mice were fasted for more than 12 hours the day before being killed, and drinking water was not restricted during the fasting period. The mice were weighed and measured before being killed and their body length was recorded. After being anesthetized, the mice's eyeballs were removed for blood collection, and then they were killed by dislocating the neck. The mice were subjected to laparotomy to obtain the testicles and fat around the kidneys.
[0082] 1.31 Body weight: Each group of mice had free access to food and water. The body weight was measured every week during the gavage period for 6 consecutive weeks. The statistical results are shown in Table 1 and Figure 1 shown.
[0083] 1.32 Lee's index: At the end of the experiment, the weight (g) of the mice before being killed was recorded, and the body length (cm) was measured. The body length was the distance from the nose tip to the anus of the mice before dissection. The Lee's index was calculated according to the following formula. The calculation results are shown in Table 2;
[0084]
[0085] 1.33 Fat coefficient: After the mice were killed, the abdominal cavity was opened and the fat around the testicles and kidneys was taken out, placed in pre-cooled physiological saline, blood and impurities were removed and the weight was weighed after absorbing with filter paper to measure the fat coefficient of the mice, that is, the ratio of the total fat mass (g) of testicular fat and kidney fat to body weight (g). The fat coefficient was calculated according to the following formula, and the calculation results are shown in Table 2.
[0086]
[0087] 1.34 After the last administration, the mice were fasted for 12 hours. The eyeballs of the mice were anesthetized and blood was collected. The centrifuge tubes containing the mouse blood were placed in a centrifuge and the speed was set at 3500 r / min. The centrifuge was performed at 4°C for 15 minutes. The supernatant was aspirated to test the levels of triglyceride (TG), cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and leptin (LEP) in the mouse serum. The results are shown in Tables 3 and Figure 2 TG, TC, LDL-C, HDL-C, and LEP kits were purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.
[0088] Table 1
[0089]
[0090] From Table 1 and Figure 1It can be seen that before oral administration, the obesity degree of mice in the model group was greater than 20%, indicating that the obese mouse model was successfully constructed; the weight of mice in the normal group has been showing an increasing trend. In the 4th and 6th weeks, compared with the model group, the body weight of Examples 1-3 and the positive control group was significantly reduced. Compared with the collagen peptide fermentation liquid and the plant enzyme group, the body weight of Example 2 was significantly reduced, indicating that the synergistic effect of the collagen peptide fermentation liquid and the plant enzyme on the body weight of mice played a role in reducing weight, and the weight loss effect on the body weight was better than when used alone; compared with Comparative Examples 1-7, the body weight of Example 2 was significantly reduced, indicating that the collagen peptide fermentation liquid and the plant enzyme played a role in reducing weight on the body weight of mice, and only the collagen peptide fermentation liquid obtained by fermentation of Lactobacillus rhamnosus NCU2217, and the plant enzyme obtained by synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu, the synergistic effect of collagen peptide fermentation liquid and plant enzyme was more significant.
[0091] Table 2
[0092]
[0093]
[0094] As shown in Table 2, compared with the model group, the Lee's index and fat coefficient of Examples 1-3 and the positive control group were significantly reduced. Compared with the collagen peptide fermentation liquid and the plant enzyme group, the Lee's index and fat coefficient of Example 2 were significantly reduced, indicating that the synergistic effect of collagen peptide fermentation liquid and plant enzyme can significantly reduce visceral fat obesity, and the reduction effect is more obvious when used in combination than when used alone; compared with comparative examples 1-7, the Lee's index and fat coefficient of Example 2 were significantly reduced, indicating that collagen peptide fermentation liquid and plant enzyme can reduce visceral fat obesity together, and only the collagen peptide fermentation liquid obtained by fermentation of Lactobacillus rhamnosus NCU2217, and the plant enzyme obtained by synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu, the synergistic reduction effect of collagen peptide fermentation liquid and plant enzyme is more significant.
[0095] As can be seen from the above, the collagen peptide composition obtained by the present invention has a significant weight loss and fat reduction effect by using the synergistic effect of collagen peptide fermentation liquid and plant enzymes.
[0096] Table 3
[0097]
[0098]
[0099] From Table 3 and Figure 2It can be seen that compared with the normal group, the TG, TC, LDL-C, and LEP of the model group were significantly increased, and HLDL-C was significantly decreased; compared with the model group, TG, TC, LDL-C, and LEP of Examples 1-3 and the positive control group were significantly increased, and HLDL-C was significantly decreased. Compared with the collagen peptide fermentation broth and the plant enzyme group, the TG, TC, LDL-C, and LEP of Example 2 were significantly increased, and the HLDL-C was significantly reduced, indicating that the synergistic effect of the collagen peptide fermentation broth and the plant enzyme has the effect of regulating lipid metabolism and improving the body's lipid metabolism disorder. The effect is more obvious when used in combination than when used alone; compared with comparative examples 1-7, the TG, TC, LDL-C, and LEP of Example 2 were significantly increased, and the HLDL-C was significantly reduced, indicating that the collagen peptide fermentation broth and the plant enzyme can regulate lipid metabolism together, and only the collagen peptide fermentation broth obtained by fermentation of Lactobacillus rhamnosus NCU2217, and the plant enzyme obtained by synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu, the synergistic effect of the collagen peptide fermentation broth and the plant enzyme on regulating lipid metabolism is more significant. Therefore, the collagen peptide composition obtained by the present invention uses the synergistic effect of the collagen peptide fermentation broth and the plant enzyme to regulate lipid metabolism and improve the body's lipid metabolism disorder.
[0100] 2. Study on the function of collagen peptide composition in regulating glucose metabolism
[0101] 2.1 Grouping and dosing: After the purchased SD rats (purchased from Hunan Slake Jingda Experimental Animal Co., Ltd.) were fed with ordinary feed in a sterile laboratory for 6 days, all rats were weighed and fasted for 4 hours. Blood was collected from the tail vein to measure fasting blood sugar, and then 250 mg / kg of glucose was gavaged according to the rat body weight. The blood sugar levels were measured 0.5 hours and 2 hours later. 90 rats with normal blood sugar were randomly divided into 15 groups with reference to blood sugar values, including 1 blank group, 1 model group, 1 positive control group, and 12 treatment groups (Example 2, Example 4-5, Comparative Example 1-7, collagen peptide fermentation broth and plant enzymes). The blank group was not treated, and the gavage dose of the model group was: 10 mL·kg of normal saline. -1 (bw / d); the oral dose of the positive control group was: metformin 107 mg·kg -1 (bw / d), based on 10 mL kg -1 (bw / d) gavage dose; the gavage dose of the treatment group was: the compositions obtained in Example 2, Examples 4-5 and Comparative Examples 1-7 were diluted 10 times with distilled water, respectively, at 10 mL·kg -1The collagen peptide fermentation broth and plant enzymes were obtained in Example 2, and diluted according to the dosage of Example 2 (collagen peptide fermentation broth 10*12 / 15 times dilution, plant enzymes 10*3 / 15 times dilution), respectively, at 10mL·kg -1 (bw / d) dose by oral gavage.
[0102] The rats were fed with normal feed from the first day to the seventh day after the gavage. From the eighth day, all rats except the blank group were fed with high-energy feed for 26 consecutive days. Normal feed, also known as SPF-grade maintenance feed for mice and rats, was purchased from Liaoning Changsheng Biotechnology Co., Ltd.; high-energy feed formula: 52.6% normal feed, 10% lard, 15% white sugar, 15% protein powder, 5% casein, 1.2% cholesterol, 0.2% sodium cholate, 0.6% calcium bicarbonate, and 0.4% stone powder.
[0103] 2.2 Establishment of type Ⅱ diabetic rat model: On the 29th day of intragastric administration, except for the blank group, the rats in other groups were fasted but not deprived of water for 24 hours. After the fasting was completed, alloxan was intraperitoneally injected at a dose of 107 mg kg -1 , and then continue to feed high-energy feed for 5 days.
[0104] 2.3 Detection indicators
[0105] 2.3.1 Determination of fasting blood glucose in experimental rats: On the 28th (before modeling) and 32nd (after modeling) days after oral administration, all experimental rats fasted for 4 hours, and blood was collected from the tail vein to measure fasting blood glucose values. The results are shown in Table 4.
[0106] 2.3.2 Glycogen determination The rats were anesthetized and killed, the abdominal cavity was opened and the liver was separated. A small piece of liver tissue was taken and processed according to the instructions of the glycogen determination kit (product A043-1-1, Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.) and the glycogen content was measured. The results are shown in Table 5 and Figure 3 .
[0107] Table 4
[0108]
[0109] As shown in Table 4, before modeling (28 days), the fasting blood glucose levels of the blank group, model group, positive control group and each treatment group fluctuated within the normal range, and there was no significant difference among the groups; after modeling (32 days), the fasting blood glucose levels of diabetic rats in the model group, positive control group and each treatment group showed an upward trend. Compared with before modeling (28 days), the blood glucose levels of rats in the model group increased the most, with an average fasting blood glucose level of 16.76 mmol / L, and the blood glucose levels of the model group increased significantly compared with those of the blank group, indicating that the diabetic rat modeling was successful. After modeling, the fasting blood glucose values of diabetic rats in each treatment group were lower than those in the model group; compared with the collagen peptide fermentation broth and plant enzyme group, the fasting blood glucose value of Example 2 was significantly reduced, indicating that the synergistic effect of collagen peptide fermentation broth and plant enzyme can significantly reduce blood glucose, and the reduction effect is more obvious when used in combination than when used alone; compared with comparative examples 1-7, the fasting blood glucose value of Example 2 was significantly reduced, indicating that collagen peptide fermentation broth and plant enzyme can reduce blood glucose together, and only the collagen peptide fermentation broth obtained by fermentation of Lactobacillus rhamnosus NCU2217, and the plant enzyme obtained by synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu, the synergistic effect of collagen peptide fermentation broth and plant enzyme to reduce blood glucose is more significant. Therefore, the collagen peptide composition obtained by the present invention has the effect of reducing blood glucose by the synergistic effect of collagen peptide fermentation broth and plant enzyme.
[0110] Table 5
[0111] Group Glycogen (mg / g) Blank Group 16.26±0.10 Model Group <![CDATA[9.41±0.07 a ]]> Positive control group <![CDATA[15.16±0.09 b ]]> Example 2 <![CDATA[15.83±0.08 bcd ]]> Example 4 <![CDATA[15.76±0.07 bcd ]]> Example 5 <![CDATA[15.87±0.10 bcd ]]> Comparative Example 1 11.53±0.04 Comparative Example 2 12.22±0.09 Comparative Example 3 12.38±0.08 Comparative Example 4 11.94±0.06 Comparative Example 5 12.76±0.07 Comparative Example 6 12.31±0.10 Comparative Example 7 12.47±0.09 Collagen peptide fermentation liquid 11.28±0.06 Plant enzymes 11.15±0.05
[0112] From Table 5 and Figure 3 It can be seen that compared with the blank group, the glycogen content in the model group was significantly reduced, indicating that the model group rats had disordered glucose metabolism. Compared with the model group, the glycogen content in the positive control group and each treatment group was significantly increased, and the positive control group and each treatment group were able to regulate the balance of glucose metabolism. Compared with the collagen peptide fermentation broth and the plant enzyme group, the glycogen content of Example 2 was significantly increased, indicating that the synergistic effect of collagen peptide fermentation broth and plant enzymes can significantly regulate the balance of glucose metabolism, and the effect of reducing the effect when used in combination is more obvious than when used alone; Compared with Comparative Examples 1-7, the glycogen content of Example 2 was significantly increased, indicating that the collagen peptide fermentation broth and plant enzymes can significantly regulate the balance of glucose metabolism together, and only the collagen peptide fermentation broth obtained by fermentation of Lactobacillus rhamnosus NCU2217, and the plant enzymes obtained by synergistic fermentation of Ganoderma lucidum, Rhizoma Alismatis and Shenqu, the synergistic effect of collagen peptide fermentation broth and plant enzymes is more significant. Therefore, continuous intragastric administration of the collagen peptide composition obtained by the present invention improves the ability of rat liver to handle hyperglycemia and helps to regulate glucose metabolism.
[0113] 3. Protective effect of collagen peptide combination on acute liver injury in mice
[0114] 3.1 Experimental grouping and administration: Eight-week-old male C57BL / 6 mice were purchased from Changzhou Cavens Experimental Animal Co., Ltd.; 78 mice were randomly divided into 13 groups, including 1 blank group, 1 model group, 1 positive control group (bifendate), and 10 treatment groups (Example 2, comparative example 1-7 groups, collagen peptide fermentation broth and plant enzymes). The blank group and the model group were gavaged with normal saline, and the gavage dose was: 10 mL·kg of normal saline -1 (bw / d); The oral dose of the positive control group was: bifendate dripping pills, 200 mg kg -1 (bw / d), based on 10 mL kg -1 (bw / d) dose gavage; the gavage dose of the treatment group was: the compositions obtained in Example 2 and Comparative Examples 1-7 were diluted 10 times with distilled water, respectively, at 10 mL·kg -1 The collagen peptide fermentation broth and plant enzymes were obtained in Example 2, and diluted according to the dosage of Example 2 (collagen peptide fermentation broth 10*12 / 15 times dilution, plant enzymes 10*3 / 15 times dilution), respectively, at 10mL·kg -1 (bw / d) dose by intragastric administration. Bifendate dripping pills were provided by Beijing Union Pharmaceutical Factory.
[0115] Except for the normal group and the model group which were gavaged with normal saline, the other groups were gavaged with the drug for 10 days. One hour after the last drug administration, the normal group was intraperitoneally injected with olive oil, and the other groups were intraperitoneally injected with 0.3% CCl4 olive oil solution (10 ml / kg). The mice were fasted but not watered. They were weighed after 24 hours, blood was collected from the eye sockets after anesthesia, and the mice were killed and their livers were dissected.
[0116] 3.2 Detection indicators
[0117] 3.2.1 Before killing the mice, weigh all mice in each model and group. After anesthesia and blood collection, kill all mice and remove the liver, rinse with 4°C saline, dry with filter paper, and weigh the liver. After collecting the data, calculate the liver coefficient of each group of mice. The results are shown in Table 6.
[0118] Liver coefficient = liver mass (g) / body weight (g) × 100%
[0119] 3.2.2 Biochemical indicators
[0120] The mouse blood obtained by the orbital blood sampling method was placed in a 4 mL procoagulant tube and centrifuged at 25°C and 3500 rpm for 15 min. The supernatant was collected to obtain serum. The ALT and AST in the mouse serum were determined using the corresponding kit according to the instructions. The results are shown in Table 6 and Figure 4A small piece of liver tissue from the same part was taken, and pre-cooled physiological saline was added at a ratio of 1:9. After homogenization, the mixture was centrifuged at 4°C and 9500rpm for 20min. The supernatant was taken as 10% liver tissue homogenate. The SOD and MDA contents in the liver tissue were determined according to the instructions of the corresponding kit. The results are shown in Table 7 and Figure 5 Among them, alanine aminotransferase (ALT) test kit, aspartate aminotransferase (AST) test kit, malondialdehyde (MDA) test kit, and superoxide dismutase (SOD) test kit were all purchased from Shanghai Bio-Tech Biotechnology Co., Ltd.
[0121] Table 6
[0122] Group ALT(U / L) AST(U / L) Liver coefficient (%) Blank Group 28.45±3.48 76.28±6.82 4.10±0.13 Model Group <![CDATA[131.52±10.37 a ]]> <![CDATA[336.47±24.18 a ]]> <![CDATA[5.26±0.17 a ]]> Positive control group <![CDATA[38.46±4.71 b ]]> <![CDATA[95.46±16.74 b ]]> <![CDATA[4.25±0.11 b ]]> Example 2 <![CDATA[41.14±3.16 bc ]]> <![CDATA[115.29±11.35 bc ]]> <![CDATA[4.31±0.10 bc ]]> Comparative Example 1 87.54±7.65 245.73±21.02 4.97±0.12 Comparative Example 2 82.47±7.21 231.32±23.17 4.93±0.09 Comparative Example 3 78.35±6.87 217.21±19.54 4.88±0.19 Comparative Example 4 85.26±7.18 238.46±22.75 4.96±0.14 Comparative Example 5 76.51±7.36 204.69±18.53 4.84±0.18 Comparative Example 6 80.16±6.27 224.95±23.14 4.90±0.08 Comparative Example 7 77.28±6.79 212.78±21.58 4.87±0.15 Collagen peptide fermentation liquid 90.15±8.20 254.15±22.51 5.02±0.14 Plant enzymes 93.42±7.42 261.57±23.82 5.09±0.13
[0123] Table 7
[0124]
[0125]
[0126] From Table 6 and Figure 4 It can be seen that compared with the blank group, the liver index of the model group mice increased significantly, and the serum ALT and AST levels of the model group mice increased significantly, indicating that the liver of the model group mice was damaged. Compared with the model group, the liver index, ALT and AST levels of each treatment group decreased, and the liver index, serum ALT and AST levels of the positive control group and Example 2 group mice decreased significantly. Compared with the collagen peptide fermentation broth and plant enzyme group, the liver index, serum ALT and AST content of mice in Example 2 group decreased significantly, indicating that the synergistic effect of collagen peptide fermentation broth and plant enzyme can significantly reduce the liver index, serum ALT and AST content of mice, and the reduction effect is more obvious when used in combination than when used alone; compared with comparative examples 1-7, the liver index, serum ALT and AST content of mice in Example 2 group decreased significantly, indicating that collagen peptide fermentation broth and plant enzyme can significantly reduce the liver index, serum ALT and AST content of mice together, and only the collagen peptide fermentation broth obtained by fermentation of Lactobacillus rhamnosus NCU2217 and the plant enzyme obtained by synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu, the synergistic effect of collagen peptide fermentation broth and plant enzyme is more significant.
[0127] From Table 7 and Figure 5It can be seen that compared with the blank group, the SOD activity in the liver of the model group mice was significantly reduced, indicating that the livers of all model group mice were damaged by oxidation; the MDA content in the liver of the model group mice was significantly increased, indicating that the livers of all model group mice had serious lipid peroxidation. Compared with the model group, the SOD activity of each treatment group was restored and the MDA content was decreased, and the SOD activity of the liver of the positive control group and Example 2 group mice increased significantly and the MDA content decreased significantly. Compared with the collagen peptide fermentation broth and the plant enzyme group, the SOD activity of the mouse liver in the Example 2 group was significantly increased and the MDA content was significantly decreased, indicating that the synergistic effect of the collagen peptide fermentation broth and the plant enzyme can significantly increase the SOD activity and reduce the MDA content of the mouse liver, and the reduction effect is more obvious when used in combination than when used alone; compared with comparative examples 1-7, the SOD activity of the mouse liver in the Example 2 group was significantly increased and the MDA content was significantly decreased, indicating that the collagen peptide fermentation broth and the plant enzyme can significantly increase the SOD activity and reduce the MDA content of the mouse liver together, and only the collagen peptide fermentation broth obtained by fermentation with Lactobacillus rhamnosus NCU2217 and the plant enzyme obtained by the synergistic fermentation of Ganoderma lucidum, Alisma orientalis and Shenqu, the synergistic effect of the collagen peptide fermentation broth and the plant enzyme is more significant.
[0128] In summary, the intervention of the collagen peptide composition obtained by the present invention significantly alleviated the liver enlargement of the acute liver injury model mice, reduced the content of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of the model mice, and alleviated the degree of liver damage. The activity of the antioxidant enzyme system was determined to find that the intervention of the collagen peptide composition obtained by the present invention significantly increased the level of SOD in the liver of the acute liver injury model mice and reduced the content of MDA, thereby alleviating the oxidative stress of the liver of the model mice.
[0129] The above-mentioned embodiments only express the specific implementation of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A collagen peptide composition for regulating metabolism, reducing weight and fat, characterized in that: It comprises collagen peptide fermentation liquid and plant enzyme, wherein the volume ratio of the collagen peptide fermentation liquid to the plant enzyme is 10-15:2-5; the collagen peptide fermentation liquid is obtained by fermenting collagen peptide with Lactobacillus rhamnosus; and the plant enzyme is obtained by fermenting a traditional Chinese medicine composition with Lactobacillus casei.
2. A collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 1, characterized in that: The volume ratio of the collagen peptide fermentation liquid to the plant enzyme is 12:
3.
3. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 1, characterized in that: The specific fermentation method of the collagen peptide fermentation liquid is: adding 3-5% (w / v) collagen peptide into water, inoculating Lactobacillus rhamnosus, and fermenting at 30-42° C. for 16-24 hours to obtain the collagen peptide fermentation liquid.
4. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 1, characterized in that: The Lactobacillus rhamnosus is Lactobacillus rhamnosus NCU2217, which is deposited in the General Microbiological Center of China National Microbiological Culture Collection Administration, with a deposit number of CGMCC NO15573.
5. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 1, characterized in that: The inoculation amount of Lactobacillus rhamnosus is 1×10 6 ~1×10 7 cfu / mL.
6. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 1, characterized in that: The traditional Chinese medicine composition comprises ganoderma lucidum, oriental water chestnut and herb Shenqu.
7. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 6, characterized in that: The weight ratio of the ganoderma lucidum, oriental water chestnut and Shenqu is 3:2:
2.
8. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 7, characterized in that: The specific preparation method of the plant enzyme is as follows: (a) mixing the Chinese medicinal materials in the Chinese medicine composition in proportion and adding the mixture into distilled water for extraction, and concentrating the obtained extract to obtain a Chinese medicine concentrate; (b) directly adding Lactobacillus casei into the Chinese medicine concentrate for inoculation and fermentation to obtain plant enzyme.
9. The collagen peptide composition for regulating metabolism, reducing weight and reducing fat according to claim 1, characterized in that: The inoculation amount of Lactobacillus casei is 1×10 6 ~1×10 7 cfu / mL.
10. Use of the collagen peptide composition according to any one of claims 1 to 9 in the preparation of health food or medicine; the health food is a health food with the effects of regulating metabolism, losing weight and reducing fat; the medicine is a medicine with the effects of regulating metabolism, losing weight and reducing fat.
Citation Information
Patent Citations
Lactobacillus rhamnosus with fatty liver disease inhibiting function and application thereof
CN109259146A
Lactobacillus rhamnosus with hyperlipidemia inhibiting effect and application of lactobacillus rhamnosus
CN109401994A
Liver-protecting and lipid-lowering composition and preparation method thereof
CN109464630A
Fermented collagen with antioxidant and moisturizing functions and preparation method and composition thereof
CN115992196A
Chlorella pyrenoidosa probiotic composition with lipid metabolism regulating function and preparation method of chlorella pyrenoidosa probiotic composition
CN116158531A
